One Capital Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

One Capital Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.14M	Sell	13,205 -2,047	-13%	-$179K	0.03%	286
2025 Q4	$1.29M	Sell	15,252 -1,742	-10%	-$139K	0.04%	261
2025 Q3	$1.23M	Sell	16,994 -2,872	-14%	-$198K	0.04%	239
2025 Q2	$1.3M	Sell	19,866 -3,077	-13%	-$200K	0.05%	190
2025 Q1	$1.62M	Sell	22,943 -6,583	-22%	-$457K	0.05%	183
2024 Q4	$1.94M	Buy	29,526 +3,777	+15%	+$260K	0.06%	162
2024 Q3	$1.82M	Sell	25,749 -1,929	-7%	-$134K	0.06%	174
2024 Q2	$1.84M	Buy	27,678 +547	+2%	+$35.8K	0.06%	172
2024 Q1	$1.84M	Sell	27,131 -499	-2%	-$33K	0.07%	145
2023 Q4	$1.71M	Buy	27,630 +21,210	+330%	+$1.25M	0.07%	152
2023 Q3	$379K	Buy	+6,420	New	+$394K	0.02%	214

Other funds holding IHE

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

MSCM

McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

ACM

Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

One Capital Management's IHE Position: Q1 2026 in Review

One Capital Management reduced its iShares US Pharmaceuticals ETF (IHE) stake by 13% in Q1 2026, selling an estimated $179K and leaving 13,205 shares worth $1.14M. The position accounts for 0.03% of the portfolio, ranked #286.

One Capital Management first reported a position in IHE in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.94M in Q4 2024. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

One Capital Management held 13,205 shares of iShares US Pharmaceuticals ETF worth $1.14M as of Q1 2026.
One Capital Management sold 2,047 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $179K.
iShares US Pharmaceuticals ETF made up 0.03% of One Capital Management's portfolio in Q1 2026, its #286 holding.
One Capital Management first reported a position in iShares US Pharmaceuticals ETF in Q3 2023 and has held it in 11 quarters since.
One Capital Management's iShares US Pharmaceuticals ETF position peaked at $1.94M in Q4 2024.
194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on One Capital Management's 13F filing for Q1 2026, filed 13 May 2026.